Methsuximide
- Strength
- 300 mg/1
- Form
- Capsule
- Class
- Anti-epileptic Agent
ANI Pharmaceuticals, Inc.
Not stocked by us — reference only
methsuximide
Listed by Parke-Davis Div of Pfizer Inc
| Dosage form | Capsule |
|---|---|
| Route | Oral |
| Drug class | Anti-epileptic Agent |
| Approval route | NDA — original brand approval |
| NDC code | 0071-0525 |
| FDA application | NDA010596 |
| RxNorm concept | 197949 |
| Package sizes listed | 1 |
| Marketed since | February 1957 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
ANI Pharmaceuticals, Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.